KL01 Modified and Decorated Adenosines Targeted at ATP/NAD Recognition Motifs     Andreas LINK(Ernst-Moritz-Arndt-University Greifswald, Germany) KL02 Histamine H3 Receptor Antagonists — From Bench to Bedside     Holger STARK(Johann Wolfgang Goethe University Frankfurt am Main, Germany) KL03 The Pharmaceutical Sciences in 2020     Vinod P. SHAH(International Pharmaceutical Federation (FIP)) SL01 Neurovascular Effects of Saturated Fatty Acids     Tony JF LEE(College of Life Sciences, USA) SL02 Life and Elements — Challenge to the Development of Metallopharmaceutics —     Hiromu SAKURAI(Fac. Pharm. Sci., Suzuka Univ. Medical Sci.) SL03 Development of New Magnetic Resonance Imaging Technique and Visualization of Oxidative Stress‐Related Diseases     Hideo UTSUMI, et al.(Fac. Pharm. Sci., Kyushu Univ.) SL04 Zinc Signaling in Immunity, Inflammation and Allergy     Toshio HIRANO(Grad. Sch. Frontier Biosci., Grad. Sch. Med., and WPI Immunol. Front. Research Cent., Osaka Univ.) SL05 PET in Drug Development     Christer HALLDIN(Karolinska Hospital, Sweden) SL06 Molecular Imaging: Contributing to Drug Research and Development     Hideo SAJI(Grad. Sch. Pharm. Sci., Kyoto Univ.) SL07 Cellular and Molecular Imaging Based on MRI     Toshiro INUBUSHI(Biomed. MR Sci. Center, Shiga Univ. Med. Sci.) SL08 MR Imaging at High Magnetic Fields—From MR Microscopy to Clinical Application: A Challenge to New Biological Information     Masaya TAKAHASHI(Univ. Texas Southwestern Medical Center, U.S.A.) SL09 Progress in Drug Transporter Research: From Bench to Bedside     Ken-ichi INUI(Dept. Pharm., Kyoto Univ. Hospital) SL10 The Sodium/Iodide Symporter (NIS): An Unending Source of Surprises     Nancy CARRASCO(Albert Einstein College of Medicine, USA) SL11 Importance of Drug Transporter Studies in the New Drug Discovery and Development     Yuichi SUGIYAMA(Grad. Sch. Pharm. Sci., Univ.Tokyo) SL12 Strange Things Happen in Small Spaces: How Synaptic Vesicles Fill with Neurotransmitter     Robert H EDWARDS(UCSF School of Medicine, USA) SL13 Regulatory Mechanism of Calcium inside the Cell and Its Role in Physiological Function—Development of New Drugs for Therapeutic Uses for Its Abnormalities     Katsuhiko MIKOSHIBA(RIKEN Brain Science Institute) SL14 Neural Mechanism of Functional Recovery after Spinal Cord Injury     Tadashi ISA(Nat. Instit. Physiol. Sci.) SL15 Multiple Learning Mechanisms in Mouse Eyeblink Conditioning     Shigenori KAWAHARA(Grad. Sch. Sci. Engineer., Univ. Toyama) SL16 Calcium Channels and Neurological Disorders     Keiji IMOTO(Nati. Instit. Physiol. Sci., Sch. Life Sci., Grad. Univ. Adv. Studies (SOKENDAI)) SL17 Origin of Complex Spike Synchronization in Neuronal Circuits     Yuji IKEGAYA(Grad. Sch. Pharm. Sci., Univ. Tokyo) SL18 Clinical Trial on DHEA in Elderly Women and DHEA or Testosterone in Elderly Men     K. Sreekumaran NAIR(Mayo Clinic, MN USA) SL19 Science and Art in Drug Development and Fostering in Japan     Shigeyuki NAKANO(Dept. Pharm. Med., Internat. Univ. Health and Welfare （IUHW）/Grad. Sch. Oita Univ. Fac. Med.) SL20 The Functions of ATP Receptors in Pain Signaling and Drug Development     Kazuhide INOUE(Grad. Sch. Pharm. Sci., Kyushu University) SL21 Multi-Template Method and Dramatype Method for Seeds Generation     Yuichi HASHIMOTO(Instit. Molecul. Cell. Biosci., Univ. Tokyo) SL22 Development of Nosyl Chemistry and Its Application to Total Synthesis     Tohru FUKUYAMA(Grad. Sch. Pharm. Sci., Univ. Tokyo) SL23 Small Molecules for Cell Biology     Motonari UESUGI(Instit. Integrated Cell-Material Sci. Instit. Chem. Res., Kyoto Univ.) SL24 Advanced Bioimaging Research     Tetsuo NAGANO(Grad. Sch. Pharm. Sci., Univ. Tokyo) SL25 Chromosomal Evolution and Its Biological Meaning in Primates     Hirohisa HIRAI(Primate Res. Instit., Kyoto Univ.) SL26 Improvement of Quality of Life (QOL) in the Patients with Cancer Chemotherapy     Ryozo OISHI(Dep.t. Pharm., Kyushu Univ. Hospital) SL27 Treatment of Vascular Diseases with Antibody Therapeutics and Platform Formation for Developing New Drugs     Masahiro NISHIBORI(Dept. Pharmacol., Okayama Univ. Grad. Sch. Med., Dentist. Pharm. Sci.) SL28 Two-Dimensional Capillary Electrophoresis for Ultrasensitive Protein Analysis     Norman DOVICHI(Univ. Washington,USA) SL29 Present Situation and Counter Measure on Pandemic Influenza H1N1 2009     Nobuhiko OKABE(Nat.l Institut. Infect. Diseases) SL30 Diterpenoids from Isodon Species and Their Bioactivities     Han-Dong SUN(Chinese Academy Sci.,P. R. China) SL31 Immunoregulation by Inhibitory Receptors     Toshiyuki TAKAI(Dept. Experiment. Immunol., Instit. Develop., Aging and Cancer, Tohoku Univ.) SL32 Membrane Transport Involved in the Accumulation of Bio-Active Compounds in Plants—Analogy an Difference to Animal Cells—     Kazufumi YAZAKI(Res. Instit. Sustainable Humanosphere, Kyoto Univ.) SL33 Physiology and Pathophysiology of Neuropeptide PACAP: Novel Roles Revealed by Gene Targeting Mouse Studies     Akemichi BABA(Grad. Sch. Pharm. Sci., Osaka Univ.)